Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy Insights From a Prospective, Single-Center Cohort Study
- 11 August 2020
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 142 (6), 611-614
- https://doi.org/10.1161/CIRCULATIONAHA.120.048925
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Pulmonary Embolism in Patients With COVID-19Circulation, 2020
- COVID-19 and its implications for thrombosis and anticoagulationBlood, 2020
- Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19Intensive Care Medicine, 2020
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort studyIntensive Care Medicine, 2020
- Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanismsBlood, 2019